These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18708862)

  • 21. Temporal change of enhancement after gadolinium injection on contrast-enhanced CMR in reperfused acute myocardial infarction.
    Matsumoto H; Matsuda T; Miyamoto K; Shimada T; Ushimaru S; Mikuri M; Yamazaki T
    J Cardiol; 2015 Jan; 65(1):76-81. PubMed ID: 24861912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute, subacute, and chronic myocardial infarction: quantitative comparison of 2D and 3D late gadolinium enhancement MR imaging.
    Goetti R; Kozerke S; Donati OF; Sürder D; Stolzmann P; Kaufmann PA; Lüscher TF; Corti R; Manka R
    Radiology; 2011 Jun; 259(3):704-11. PubMed ID: 21467254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose gadobenate dimeglumine versus standard-dose gadopentate dimeglumine for delayed contrast-enhanced cardiac magnetic resonance imaging.
    Balci NC; Inan N; Anik Y; Erturk MS; Ural D; Demirci A
    Acad Radiol; 2006 Jul; 13(7):833-9. PubMed ID: 16777557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The role of first pass and delayed contrast-enhancement magnetic resonance imaging in patients with myocardial infarction].
    Ma JY; Qian JY; Ge JB; Yang S; Ge L; Liu XB; Lin JY; Hu XY; Zhang F; Zhang SH; Huang RC; Li YL; Shi HY; Fan B
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Nov; 33(11):1027-30. PubMed ID: 16563254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of contrast agent dose and image acquisition timing on the quantitative determination of nonviable myocardial tissue using delayed contrast-enhanced magnetic resonance imaging.
    Petersen SE; Mohrs OK; Horstick G; Oberholzer K; Abegunewardene N; Ruetzel K; Selvanayagam JB; Robson MD; Neubauer S; Thelen M; Meyer J; Kreitner KF
    J Cardiovasc Magn Reson; 2004; 6(2):541-8. PubMed ID: 15137338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of myocardial viability using delayed enhancement magnetic resonance imaging at 3.0 Tesla.
    Klumpp B; Fenchel M; Hoevelborn T; Helber U; Scheule A; Claussen C; Miller S
    Invest Radiol; 2006 Sep; 41(9):661-7. PubMed ID: 16896300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reproducibility of chronic and acute infarct size measurement by delayed enhancement-magnetic resonance imaging.
    Thiele H; Kappl MJ; Conradi S; Niebauer J; Hambrecht R; Schuler G
    J Am Coll Cardiol; 2006 Apr; 47(8):1641-5. PubMed ID: 16631003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of infarct size changes with delayed contrast-enhanced magnetic resonance imaging and electrocardiogram QRS scoring during the 6 months after acutely reperfused myocardial infarction.
    Bang LE; Ripa RS; Grande P; Kastrup J; Clemmensen PM; Wagner GS
    J Electrocardiol; 2008; 41(6):609-13. PubMed ID: 18790502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perfusion MRI at rest in subacute and chronic myocardial infarct.
    Hopp E; Bjørnerud A; Lunde K; Solheim S; Aakhus S; Arnesen H; Forfang K; Edvardsen T; Smith HJ
    Acta Radiol; 2013 May; 54(4):401-11. PubMed ID: 23401603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamic contrast-enhanced magnetic resonance imaging measurements in renal cell carcinoma: effect of region of interest size and positioning on interobserver and intraobserver variability.
    Braunagel M; Radler E; Ingrisch M; Staehler M; Schmid-Tannwald C; Rist C; Nikolaou K; Reiser MF; Notohamiprodjo M
    Invest Radiol; 2015 Jan; 50(1):57-66. PubMed ID: 25260094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined first-pass perfusion and viability study at MR imaging in patients with non-ST segment-elevation acute coronary syndromes: feasibility study.
    Chiu CW; So NM; Lam WW; Chan KY; Sanderson JE
    Radiology; 2003 Mar; 226(3):717-22. PubMed ID: 12601212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a novel time-efficient protocol for gadobenate dimeglumine (Gd-BOPTA)-enhanced liver magnetic resonance imaging.
    Schneider G; Altmeyer K; Kirchin MA; Seidel R; Grazioli L; Morana G; Saini S
    Invest Radiol; 2007 Feb; 42(2):105-15. PubMed ID: 17220728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A fast navigator-gated 3D sequence for delayed enhancement MRI of the myocardium: comparison with breathhold 2D imaging.
    Nguyen TD; Spincemaille P; Weinsaft JW; Ho BY; Cham MD; Prince MR; Wang Y
    J Magn Reson Imaging; 2008 Apr; 27(4):802-8. PubMed ID: 18302233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multislice computed tomography and magnetic resonance imaging for the assessment of reperfused acute myocardial infarction.
    Baks T; Cademartiri F; Moelker AD; Weustink AC; van Geuns RJ; Mollet NR; Krestin GP; Duncker DJ; de Feyter PJ
    J Am Coll Cardiol; 2006 Jul; 48(1):144-52. PubMed ID: 16814660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time elapsed after contrast injection is crucial to determine infarct transmurality and myocardial functional recovery after an acute myocardial infarction.
    Rodríguez-Palomares JF; Ortiz-Pérez JT; Lee DC; Bucciarelli-Ducci C; Tejedor P; Bonow RO; Wu E
    J Cardiovasc Magn Reson; 2015 May; 17(1):43. PubMed ID: 26024662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction.
    Kim RJ; Wu E; Rafael A; Chen EL; Parker MA; Simonetti O; Klocke FJ; Bonow RO; Judd RM
    N Engl J Med; 2000 Nov; 343(20):1445-53. PubMed ID: 11078769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discrimination of myocardial acute and chronic (scar) infarctions on delayed contrast enhanced magnetic resonance imaging with intravascular magnetic resonance contrast media.
    Saeed M; Weber O; Lee R; Do L; Martin A; Saloner D; Ursell P; Robert P; Corot C; Higgins CB
    J Am Coll Cardiol; 2006 Nov; 48(10):1961-8. PubMed ID: 17112985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myocardial Late Gadolinium Enhancement: Accuracy of T1 Mapping-based Synthetic Inversion-Recovery Imaging.
    Varga-Szemes A; van der Geest RJ; Spottiswoode BS; Suranyi P; Ruzsics B; De Cecco CN; Muscogiuri G; Cannaò PM; Fox MA; Wichmann JL; Vliegenthart R; Schoepf UJ
    Radiology; 2016 Feb; 278(2):374-82. PubMed ID: 26230908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic contrast-enhanced magnetic resonance imaging assessment of kidney function and renal masses: single slice versus whole organ/tumor.
    Winter KS; Helck AD; Ingrisch M; Staehler M; Stief C; Sommer WH; Braunagel M; Kazmierczak PM; Reiser MF; Nikolaou K; Notohamiprodjo M
    Invest Radiol; 2014 Nov; 49(11):720-7. PubMed ID: 24901546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of transmural extent of infarction with contrast echocardiographically derived index of myocardial blood flow and myocardial blood volume fraction: comparison with contrast-enhanced magnetic resonance imaging.
    Choi EY; Seo HS; Park S; Kim HJ; Ahn JA; Ko YG; Choi BW; Kang SM; Choi D; Ha JW; Rim SJ; Jang Y; Chung N
    J Am Soc Echocardiogr; 2006 Oct; 19(10):1211-9. PubMed ID: 17000359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.